ES2007309A4 - Secrecion del factor de crecimiento insulinoide 1 en e.coli. - Google Patents

Secrecion del factor de crecimiento insulinoide 1 en e.coli.

Info

Publication number
ES2007309A4
ES2007309A4 ES88870067T ES88870067T ES2007309A4 ES 2007309 A4 ES2007309 A4 ES 2007309A4 ES 88870067 T ES88870067 T ES 88870067T ES 88870067 T ES88870067 T ES 88870067T ES 2007309 A4 ES2007309 A4 ES 2007309A4
Authority
ES
Spain
Prior art keywords
secretion
coli
growth factor
insulinoid
insulinoid growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES88870067T
Other languages
English (en)
Other versions
ES2007309T3 (es
Inventor
Edith Wong
Michael Louis Bittner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Technology LLC
Monsanto Co
Original Assignee
Monsanto Technology LLC
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Technology LLC, Monsanto Co filed Critical Monsanto Technology LLC
Publication of ES2007309A4 publication Critical patent/ES2007309A4/es
Application granted granted Critical
Publication of ES2007309T3 publication Critical patent/ES2007309T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A UN METODO PARA PRODUCIR BACTERIALMENTE IGF-1, EN EL QUE SE ACTUA SOBRE BACTERIAS GRAM-NEGATIVAS PARA QUE EXPRESEN UN GEN CONSISTENTE EN UNA SECUENCIA SEÑAL LAM B O MPF OPERATIVAMENTE UNIDA A UNA SECUANCIA ADN QUE CODIFICA Y PRODUCE EL IGF-1, EL CUAL ES SECRETADO EN EL ESPACIO PERIPLASMICO DE LAS BACTERIAS.
ES88870067T 1987-04-23 1988-04-22 Secrecion del factor de crecimiento insulinoide 1 en e.coli. Expired - Lifetime ES2007309T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4189687A 1987-04-23 1987-04-23

Publications (2)

Publication Number Publication Date
ES2007309A4 true ES2007309A4 (es) 1989-06-16
ES2007309T3 ES2007309T3 (es) 1994-11-01

Family

ID=21918925

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88870067T Expired - Lifetime ES2007309T3 (es) 1987-04-23 1988-04-22 Secrecion del factor de crecimiento insulinoide 1 en e.coli.

Country Status (6)

Country Link
EP (1) EP0288451B1 (es)
AT (1) ATE109828T1 (es)
AU (1) AU607209B2 (es)
CA (1) CA1314507C (es)
DE (1) DE3850995T2 (es)
ES (1) ES2007309T3 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963665A (en) * 1986-01-07 1990-10-16 Washington University Human preproinsulin-like growth factor I
US4876242A (en) * 1987-09-21 1989-10-24 Merck & Co., Inc. Human insulin-like growth factor analoges with reduced binding to serum carrier proteins and their production in yeast
DE3901681A1 (de) * 1989-01-21 1990-07-26 Behringwerke Ag Signalpeptid fuer die sekretion von peptiden in escherichia coli, verfahren zu seiner gewinnung und seine verwendung
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
AU8492291A (en) * 1990-08-28 1992-03-17 E.I. Du Pont De Nemours And Company A method for rapid selection of efficient secretion vectors
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
EP0956041A1 (en) * 1996-09-16 1999-11-17 Dalhousie University Use of igf-i for the treatment of polycystic kidney disease and related indications
US6593290B1 (en) 1996-11-01 2003-07-15 Genentech, Inc. Treatment of inner ear hair cells
US6156728A (en) * 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6121416A (en) * 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
ES2329220T3 (es) 1999-01-06 2009-11-24 Genentech, Inc. Variantes mutantes del factor de crecimiento similar a insulina (igf) i.
AU762351B2 (en) 1999-01-06 2003-06-26 Genentech Inc. Insulin-like growth factor (IGF) I mutant variants
ES2208305T3 (es) 1999-04-08 2004-06-16 Genentech, Inc. Composicion basada en polipeptidos de carga opuesta..
AU2001263215A1 (en) 2000-05-16 2001-11-26 Genentech Inc. Method for treating cartilage disorders
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
DK2274978T3 (en) 2003-09-12 2015-06-15 Ipsen Biopharmaceuticals Inc Methods of treating an insulin-like growth factor-I (IGF-I) deficiency
BRPI0416807A (pt) 2003-11-21 2007-01-09 Dow Global Technologies Inc sistemas de expressão aperfeiçoados com secreção de sistema sec
CN101031655A (zh) 2004-07-26 2007-09-05 陶氏环球技术公司 通过株工程改进蛋白表达的方法
WO2007094842A2 (en) 2005-12-02 2007-08-23 Genentech, Inc. Binding polypeptides and uses thereof
EP1957531B1 (en) 2005-11-07 2016-04-13 Genentech, Inc. Binding polypeptides with diversified and consensus vh/vl hypervariable sequences
RU2337964C2 (ru) * 2006-11-21 2008-11-10 Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pAS-2, КОДИРУЮЩАЯ ПОЛИПЕПТИД ПРОИНСУЛИНА Aspart ЧЕЛОВЕКА, И ШТАММ БАКТЕРИЙ Escherichia coli BAS2 - ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ПРОИНСУЛИНА Aspart
KR101491867B1 (ko) 2007-01-31 2015-02-10 피페넥스 인크. 증가된 발현을 위한 박테리아 리더 서열
US9394571B2 (en) 2007-04-27 2016-07-19 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US8318481B2 (en) 2007-12-07 2012-11-27 Pfenex Inc. High copy number self-replicating plasmids in pseudomonas
WO2017074566A1 (en) * 2015-10-30 2017-05-04 Dean Falb Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4336336A (en) * 1979-01-12 1982-06-22 President And Fellows Of Harvard College Fused gene and method of making and using same
EP0138644B1 (en) * 1983-08-23 1991-08-21 Mitsubishi Kasei Corporation Novel plasmid vectors

Also Published As

Publication number Publication date
DE3850995T2 (de) 1995-03-16
EP0288451A2 (en) 1988-10-26
ES2007309T3 (es) 1994-11-01
EP0288451A3 (en) 1989-04-19
CA1314507C (en) 1993-03-16
AU1509188A (en) 1988-10-27
ATE109828T1 (de) 1994-08-15
EP0288451B1 (en) 1994-08-10
DE3850995D1 (de) 1994-09-15
AU607209B2 (en) 1991-02-28

Similar Documents

Publication Publication Date Title
ES2007309T3 (es) Secrecion del factor de crecimiento insulinoide 1 en e.coli.
AU524856B2 (en) Method of making a selected protein
ES8705521A1 (es) Un metodo de producir un polipetido similar a factor de necrosis de tumores (tnf) de mamiferos.
ES2059354T3 (es) Un metodo para producir un polipeptido.
ATE188996T1 (de) Dna-sequenzen kodierend für neuartige wachstums- /differentierungsfaktoren
ES509222A0 (es) Un metodo para producir una molecula de adn recombinante caracterizada por una secuencia de adn codificada de un coni- peptido semejante al, interferon humano.
ES2060580T3 (es) Adn que tiene una secuencia adn codificante de la proteina flagelina y vector que la contiene.
ES2103274T3 (es) Metodo de produccion de proteinas de fusion.
MX9606013A (es) Lacasas purificadas de myceliophthora y acidos nucleicos que codifican para las mismas.
ES2065303T5 (es) Procedimiento de diagnosis y vacuna especifica.
HUT52544A (en) Process for production of artery-system anticoagulant proteins and dns coding them
MX9203379A (es) Proteinas producidas por los linfocitos humanos, secuencia de adn que codifica para estas proteinas y composiciones farmaceuticas que las contienen.
PT88329A (pt) Bacterias nao virulentas contra infeccoes estreptococicas
ES2006925A6 (es) Procedimiento para la preparacion de vectores de expresion.
ES2067443T3 (es) Mejoras en o relativas a microorganismos productores de antibioticos de tilosina.
ES554856A0 (es) Un metodo de produccion de una enzima bacteriana
ATE409235T1 (de) Verfahren zur herstellung von ascorbinsäurezwischenprodukten in wirtszellen
SE8803071L (sv) Bakteriebehandling foer att bevara hoekvalitet genom att tillaegga genius bacillus mikroorganismer
DK457385D0 (da) Antibiotikum a 40926 kompleks og dets rene faktorer pa, pb, a, b og b 0
ES2108228T3 (es) Factor de diferenciacion de megacariocitos.
AR010218A1 (es) Una familia de proteinas bacterianas multi-unidad
ATE89318T1 (de) Verfahren zur gentechnologischengewinnung von proteinen unter verwendung gramnegativer wirtzellen.
MX9200917A (es) Produccion de plantas resistentes a los ataques de sclerotinia sclerotiorum por introduccion de un gen que codifica una oxalato-oxidasa.
FI102191B (fi) Menetelmä 3-des-hydroksikystatiini C:n tuottamiseksi ja menetelmässä k äytettävä DNA-sekvenssi
AR039846A1 (es) Molecula de acido nucleico que codifica un antigeno de muc-1, siendo dicha molecula capaz de producir una respuesta inmune in vivo

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 288451

Country of ref document: ES